Cubist Systematic Strategies’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-30,037
Closed -$1.73M 2962
2025
Q2
$1.73M Buy
+30,037
New +$2.41M 0.01% 1635
2024
Q4
Sell
-13,292
Closed -$804K 2922
2024
Q3
$1.31M Buy
+13,292
New +$1.72M 0.01% 1671
2024
Q2
Sell
-21,832
Closed -$3.11M 2898
2024
Q1
$3.33M Buy
+21,832
New +$3.63M 0.02% 1250
2023
Q3
Sell
-9,159
Closed -$4.14M 3283
2023
Q2
$3.97M Sell
9,159
-6,808
-43% -$3.83M 0.03% 987
2023
Q1
$9.48M Buy
15,967
+7,425
+87% +$4.16M 0.06% 481
2022
Q4
$3.45M Sell
8,542
-14,409
-63% -$6.76M 0.02% 1361
2022
Q3
$13.4M Buy
22,951
+22,399
+4,058% +$13.4M 0.08% 306
2022
Q2
$301K Buy
552
+164
+42% +$82.9K ﹤0.01% 3436
2022
Q1
$246K Sell
388
-306
-44% -$158K ﹤0.01% 2948
2021
Q4
$469K Sell
694
-811
-54% -$493K ﹤0.01% 2493
2021
Q3
$986K Sell
1,505
-4,420
-75% -$3.78M 0.01% 1539
2021
Q2
$6.01M Buy
+5,925
New +$5.19M 0.07% 435

Other funds holding AGL

Cubist Systematic Strategies's AGL Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Agilon Health (AGL) in Q3 2025, closing a stake of 30,037 shares — an estimated $1.73M sold.

Cubist Systematic Strategies first reported a position in AGL in Q2 2021 and held it in 12 quarters. The position peaked at $13.4M in Q3 2022. 190 funds tracked by Wall St. Rank hold AGL as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Agilon Health position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 30,037 Agilon Health shares in Q3 2025, an estimated $1.73M.
  • Cubist Systematic Strategies first reported a position in Agilon Health in Q2 2021 and held it in 12 quarters.
  • Cubist Systematic Strategies's Agilon Health position peaked at $13.4M in Q3 2022.
  • 190 funds tracked by Wall St. Rank held Agilon Health as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.